DRUG DISCOVERY AI FACTORY

Serial Number 79393432
Registration 7665758
700

Registration Progress

Application Filed
Dec 13, 2023
Under Examination
Approved for Publication
Dec 10, 2024
Published for Opposition
Dec 10, 2024
Registered
Jan 28, 2025

Basic Information

Serial Number
79393432
Registration Number
7665758
Filing Date
December 13, 2023
Registration Date
January 28, 2025
Published for Opposition
December 10, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 28, 2025
Registration
Registered
Classes
009 035 041 042

Rights Holder

FRONTEO, Inc.

03
Address
Meisan Takahama Building 7F,
2-12-23 Kounan, Minato-ku Tokyo 108-0075
JP

Ownership History

FRONTEO, Inc.

Original Applicant
03
JP

FRONTEO, Inc.

Owner at Publication
03
JP

FRONTEO, Inc.

Original Registrant
03
JP

Legal Representation

Attorney
Tomoko Nakajima

USPTO Deadlines

Next Renewal Deadline
2030 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-01-28)
Due Date
January 28, 2031
Grace Period Ends
July 28, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description
Apr 29, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 28, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 28, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Dec 10, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 10, 2024 PUBO A PUBLISHED FOR OPPOSITION
Dec 4, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 14, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2024 CORN I CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 25, 2024 RFNT P REFUSAL PROCESSED BY IB
Aug 7, 2024 RFRR P REFUSAL PROCESSED BY MPU
Aug 7, 2024 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 21, 2024 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 20, 2024 CNRT R NON-FINAL ACTION WRITTEN
Jul 11, 2024 DOCK D ASSIGNED TO EXAMINER
Jun 30, 2024 CRCV M CORRECTION TRANSACTION RECEIVED FROM IB
Apr 23, 2024 MAFR O APPLICATION FILING RECEIPT MAILED
Apr 18, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 16, 2024 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 11, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB

Detailed Classifications

Class 009
Downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; downloadable computer programs for proposing and searching indications; downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; devices for analyzing electronic images; downloadable computer programs for data processing; devices for data processing; computer hardware for data processing
Class 035
Compilation of information into computer databases for research in the field of pharmaceuticals
Class 041
Providing information on educational and instruction services relating to medicine and pharmaceuticals; arranging and conducting seminars relating to medicine and pharmaceuticals; instruction services in the field of pharmaceuticals
Class 042
Providing on-line non-downloadable computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; providing on-line non-downloadable computer programs for proposing and searching indications; providing on-line non-downloadable computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; provision of information search engines via internet; designing and creating services of home pages and websites; designing, programming, and maintenance of computer programs for selecting target molecules and genes for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between target molecules and diseases for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between genes and diseases for the purpose of developing and creating drugs; designing, programming, and maintenance of computer programs for proposing and searching indications; designing, programming, and maintenance of computer programs for hypothesis generation regarding some relationships between certain modalities and their indications; scientific testing, inspection and research for making a hypothesis on relationships between genes and diseases; testing, inspection or research of pharmaceuticals; consulting services relating to testing, inspection and research of pharmaceuticals; providing information on research of pharmaceuticals; drug discovery services; research and scientific inspection of pharmaceuticals relating to genetic analysis; scientific testing and research on health equipment; rental of measuring and testing instruments; rental of measuring apparatus; hosting web portals on the Internet; rental of server memory space for social networking websites; rental of computers

Classification

International Classes
009 035 041 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
DRUG DISCOVERY AI